28 related articles for article (PubMed ID: 32234828)
21. BMP4 inhibits glioblastoma invasion by promoting E-cadherin and claudin expression.
Zhao X; Sun Q; Dou C; Chen Q; Liu B
Front Biosci (Landmark Ed); 2019 Mar; 24(6):1060-1070. PubMed ID: 30844730
[TBL] [Abstract][Full Text] [Related]
22. Growth-Inhibitory Activity of Bone Morphogenetic Protein 4 in Human Glioblastoma Cell Lines Is Heterogeneous and Dependent on Reduced SOX2 Expression.
Dalmo E; Johansson P; Niklasson M; Gustavsson I; Nelander S; Westermark B
Mol Cancer Res; 2020 Jul; 18(7):981-991. PubMed ID: 32234828
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma.
Xi G; Best B; Mania-Farnell B; James CD; Tomita T
Neoplasia; 2017 Apr; 19(4):261-270. PubMed ID: 28278424
[TBL] [Abstract][Full Text] [Related]
24. Sox2: regulation of expression and contribution to brain tumors.
Mansouri S; Nejad R; Karabork M; Ekinci C; Solaroglu I; Aldape KD; Zadeh G
CNS Oncol; 2016 Jul; 5(3):159-73. PubMed ID: 27230973
[TBL] [Abstract][Full Text] [Related]
25. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
Lefort S; Maguer-Satta V
Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
[TBL] [Abstract][Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
